RYTM Rhythm Pharmaceuticals Inc.

28.78
-1.19  -4%
Previous Close 29.97
Open 30.21
Price To Book 3.67
Market Cap 990340666
Shares 34,410,725
Volume 99,321
Short Ratio
Av. Daily Volume 135,804

SEC filingsSee all SEC filings

  1. 8-K - Current report 19514360
  2. S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers 181173571
  3. 8-K - Current report 181173247
  4. 8-K - Current report 181172126
  5. 10-Q - Quarterly report [Sections 13 or 15(d)] 181171421

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 updated data due 1Q 2019.
Setmelanotide
POMC Heterozygous Deficiency Obesity, Alstrom Syndrome, POMC Epigenetic Disorders
Phase 3 data due 2020.
Setmelanotide
Alstrom Syndrome and Bardet-Biedl Syndrome
Phase 3 initial data due 3Q 2019.
Setmelanotide
Leptin Receptor Deficiency Obesity
Phase 3 initial data due 3Q 2019.
Setmelanotide
POMC deficiency obesity